Zhejiang Hisun Pharmaceutical Co Ltd 2021 Sustainability Report
Company: Zhejiang Hisun Pharmaceutical Co Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: Sustainability Report
Pages: 39
The report presents the company's 2021 consolidated operating income of 1,213,646.58万元, environmental investment of 9,074.72万元, and a workforce of 3,044 employees. It also highlights extensive EHS management, including pollution prevention, safety programs, and environmental investment. Employee development remained a focus, with 70.75 training hours per employee and a 100% training-coverage rate reported. The report further describes continued pharmaceutical R&D and the launch of an independently developed innovative drug.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.